Aytu biopharma to participate in september 2022 investor conferences

Englewood, co / accesswire / august 24, 2022 / aytu biopharma, inc. (nasdaq:aytu), a pharmaceutical company focused on commercializing novel therapeutics, with a development pipeline addressing rare, pediatric-onset disorders, today announced that aytu's management team will virtually present at, and participate in, the upcoming h.c. wainwright 24th annual global investment conference and lytham partners fall 2022 investor conference.
AYTU Ratings Summary
AYTU Quant Ranking